Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,535,270
+$365,323 QoQ
Shares Held
1,280
+0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#2,747
of 4,604 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Werba Rubin Papier Wealth Management holds $6,239,917 across 8 Drug Manufacturers - General names. LLY ranks #1 (24.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,280 | $1,535,270 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
8,749 | $1,105,348 | |
| 3 | JNJ |
Johnson & Johnson
|
4,317 | $1,096,388 | |
| 4 | ABBV |
AbbVie Inc.
|
4,226 | $1,063,430 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,214 | $669,999 | |
| 6 | AMGN |
Amgen Inc
|
800 | $289,696 | |
| 7 | PFE |
Pfizer Inc
|
10,583 | $254,838 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,904 | $224,948 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,535,270 | 1,280 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $1,169,947 | 1,272 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $858,669 | 799 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $520,366 | 682 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $470,056 | 603 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $445,165 | 539 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $358,208 | 464 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $450,057 | 508 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $357,625 | 395 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||